Loading viewer...
investor_presentation
Format: PDF investor_presentation
Verrica Pharmaceuticals presents company overview highlighting the FDA approval of YCANTH™, the first FDA-approved treatment for molluscum contagiosum. The presentation covers Verrica's business strategy, clinical programs, and commercial launch plans for its lead product candidate.
investor_presentation
54 Pages
investor_presentation
44 Pages
Orbia
Vulcan Materials Investor Presentation 2019
investor_presentationinvestor_presentation
30 Pages
Vulcan Materials Company
Dave & Buster's Entertainment Investor Presentation — March 2022
investor_presentationinvestor_presentation
6 Pages
Dave & Buster’s Entertainment